Correlation Between Antisense Therapeutics and Alterola Biotech

Can any of the company-specific risk be diversified away by investing in both Antisense Therapeutics and Alterola Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antisense Therapeutics and Alterola Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Antisense Therapeutics Limited and Alterola Biotech, you can compare the effects of market volatilities on Antisense Therapeutics and Alterola Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antisense Therapeutics with a short position of Alterola Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antisense Therapeutics and Alterola Biotech.

Diversification Opportunities for Antisense Therapeutics and Alterola Biotech

-0.25

Correlation Coefficient

Antisense Therapeutics  Alterola Biotech

Very good diversification

The 3 months correlation between Antisense and Alterola is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Antisense Therapeutics Limited and Alterola Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterola Biotech and Antisense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antisense Therapeutics Limited are associated (or correlated) with Alterola Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterola Biotech has no effect on the direction of Antisense Therapeutics i.e., Antisense Therapeutics and Alterola Biotech go up and down completely randomly.

Pair Corralation between Antisense Therapeutics and Alterola Biotech

Assuming the 90 days horizon Antisense Therapeutics Limited is expected to generate 1.94 times more return on investment than Alterola Biotech. However, Antisense Therapeutics is 1.94 times more volatile than Alterola Biotech. It trades about 0.12 of its potential returns per unit of risk. Alterola Biotech is currently generating about 0.07 per unit of risk. If you would invest  1.20  in Antisense Therapeutics Limited on September 14, 2024 and sell it today you would earn a total of  3.00  from holding Antisense Therapeutics Limited or generate 250.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Antisense Therapeutics Limited  vs.  Alterola Biotech

Antisense Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Antisense Therapeutics Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile forward-looking indicators, Antisense Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Alterola Biotech

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Alterola Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Alterola Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Antisense Therapeutics and Alterola Biotech

The main advantage of trading using opposite Antisense Therapeutics and Alterola Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antisense Therapeutics position performs unexpectedly, Alterola Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterola Biotech will offset losses from the drop in Alterola Biotech's long position.

The idea behind Antisense Therapeutics Limited and Alterola Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.